Mereo BioPharma Group plc · Drugmakers

MREO

High riskNext report: Around Nov 9 (est.)

View price ↗

The short version

A profitable company with shrinking sales. Institutions are trimming.

Going well

Profitable
No debt reported
High return on equity: 82%

Watch out for

Sales down 100% in the latest quarter vs a year ago
Share count growing 9.7% a year

Money moves

No insider buying or selling in the last 30 days
Institutions cut 25% from their holdings in the quarter ending June 2026 (27 bought, 29 sold)

Facts from SEC filings, not a recommendation.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

Sep '23Tap a barJun '26

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/4Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.82.2%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$31.0M
MissShare count not growingNot diluting owners. Falling means buybacks.+32.1% in 3 years

Revenue: $500K
Total debt: None; 0.00x equity
Current ratio: 10.46x; short-term assets / bills due
Free cash flow: -$31.0M

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: net margin 10%+, profitable every year, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 11

Revenue: $0; -100.0% YoY
EPS: -$0.01; vs -$0.02
Free cash flow: -$6.0M
Share count: +0.5%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 0.4
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Distributing-24.9%

Institutions cut 24.9% from their holdings. 27 bought, 29 sold.

Shares held by institutions56.6M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+9.7%

Cash runwayAt last year's cash burn

12 months

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

798M

Why high risk

Losing money, losses are large next to sales
About 12 months of cash left at its current burn
Exchange listing notice (a delisting warning or a move to another exchange)

Earnings reports

Last 10

Next reportAround Nov 9 (est.)Estimated from the same quarter last year

Results filedAug 11
Results filedMar 19
Results filedNov 10, 2025
Results filedAug 12, 2025
Results filedMay 13, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Listing standards noticeAug 19 · View filing ↗Red flag 5%+ holder update (passive)Aug 14 · View filing ↗Big holder Listing standards noticeFeb 17 · View filing ↗Red flag

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Listing standards noticeAug 19 · Form 8-K ↗5%+ holder update (passive)Aug 14 · Form SCHEDULE 13G/A ↗Major agreementAug 11 · Form 8-K ↗Earnings resultsAug 11 · Form 8-K ↗Quarterly reportAug 11 · Form 10-Q ↗5%+ holder update (passive)May 15 · Form SCHEDULE 13G/A ↗Shareholder vote resultsMay 14 · Form 8-K ↗New 5%+ holder (passive)May 14 · Form SCHEDULE 13G ↗Acquisition or sale completedMay 12 · Form 8-K ↗Quarterly reportMay 12 · Form 10-Q ↗Earnings resultsMay 12 · Form 8-K/A ↗Proxy statementApr 9 · Form DEF 14A ↗ARSApr 9 · Form ARS ↗Leadership changeMar 27 · Form 8-K ↗PRE 14AMar 27 · Form PRE 14A ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page